Pharming Group N.V. announced that Robert Friesen, Chief Scientific Officer and Executive Board member resigned from his role. Mr. Friesen's succession is currently under review.
Market Closed -
Other stock markets
|
Pre-market 11:14:04 am | |||
0.8225 EUR | +1.54% | 0.833 | +1.28% |
21/05 | Transcript : Pharming Group N.V. - Shareholder/Analyst Call | |
08/05 | Transcript : Pharming Group N.V., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.22% | 601M | |
+39.82% | 734B | |
+31.34% | 591B | |
-7.31% | 350B | |
+14.23% | 315B | |
+0.86% | 276B | |
+13.47% | 238B | |
-6.63% | 204B | |
+7.49% | 206B | |
+4.51% | 161B |
- Stock Market
- Equities
- PHARM Stock
- News Pharming Group N.V.
- Pharming Group N.V. Announces Resignation of Robert Friesen, Chief Scientific Officer and Executive Board Member